OVH (OTC:OVHGY) Stock, Quote.Headers.trade-ideas

OVH Groupe is a provider of cloud services, occupying a unique position in the cloud market. It provides businesses with a complete suite of solutions designed to meet the growing demand for multi-cloud and hybrid cloud strategies, addressing a wide range of needs and customer segments.

OVH Groupe

A coalition of cannabis advocates is ramping up pressure on President Joe Biden to act on his promise of <a href="https://www.benzinga.com/markets/cannabis/24/06/39319868/meet-the-man-who-did-prison-time-for-non-violent-cannabis-offense-and-now-advocates-for-others-i">cannabis justice. </a>
On Tuesday, the Last Prisoner Project (LPP) and several partner organizations announced the Countdown for Clemency campaign, urging Biden to grant clemency to nearly 3,000 individuals still incarcerated for federal marijuana offenses, Marijuana Moment <a href="https://www.marijuanamoment.net/marijuana-reform-advocates-launch-countdown-to-clemency-campaign-pressing-biden-to-free-cannabis-prisoners-before-his-term-ends/">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/04/38412810/president-biden-pardons-commutes-16-non-violent-drug-offenders-cannabis-prisoners-excluded">President Biden Pardons, Commutes 16 Non-Violent Drug Offenders: Cannabis Prisoners Excluded</a>
<h3 class="wp-block-heading">Activists Call For Broader Action</h3>
Despite Biden&#8217;s past efforts, which included pardoning thousands of people with federal cannabis possession convictions, no one has been released from prison as a result. 
The new campaign is pushing the president to use his clemency powers to right this wrong. "Time is running out on President Biden's term, but it is not too late for him to undo the harms inflicted on families impacted by cannabis criminalization," said Sarah Gersten, executive director of LPP.
The campaign's website features a large countdown clock, symbolizing the dwindling time before Biden's term ends. While Biden's pardons have helped people clear their records, the administration has not commuted the sentences of those still behind bars for cannabis-related offenses.
Recent polls show that Americans overwhelmingly support clemency for those incarcerated for marijuana offenses, now legal in many states. 84% of voters support releasing people serving time for cannabis crimes, while 72% approve of Biden's previous pardons for non-violent possession convictions.
<h3 class="wp-block-heading">Congressional Push Adds Weight</h3>
The campaign for clemency has gained momentum in Congress, where 36 lawmakers wrote to Biden in March, urging him to commute the sentences of non-violent cannabis offenders. 
Biden, however, has maintained a cautious stance. At a Wisconsin campaign stop earlier this year, he expressed his support for rescheduling marijuana but drew a distinction between users and dealers. "If you're out selling it, if you're out growing, it's a different deal," Biden said.
<h3 class="wp-block-heading">The Clock Is Ticking As November Elections Loom</h3>
With the 2024 election approaching, the administration appears aware of the growing public demand for cannabis reform. 
Both Biden and Vice President Kamala Harris have emphasized their efforts to address the issue, including a carefully timed announcement on April 20, a significant date in cannabis culture.
Harris has also publicly called on the Drug Enforcement Administration (DEA) to speed up its review of marijuana's classification under federal law.
With only months left in Biden&#8217;s presidency, the clock is ticking for thousands of individuals still serving time for cannabis offenses.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39998398/kamala-harris-admits-i-inhaled-marijuana-and-now-pushes-for-legalization-what-this-means-for-202">Kamala Harris Admits &#8216;I Inhaled&#8217; Marijuana And Now Pushes For Legalization: What This Means For 2024 Elections</a></li>
</ul>

Cannabis

Government

News

Regulations

Politics

Legal

Markets

Biden Faces Pressure To Release Thousands Imprisoned For Federal Cannabis Convictions

SNDL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) announced on Tuesday that Taranvir &#8220;Tank&#8221; Vander, president of its Liquor Division, is stepping down after two decades of leadership in the liquor industry. Vander, who began his career as a liquor store manager in the early 2000s, is retiring to pursue new opportunities.
In 2013, Vander founded Ace Liquor Corporation, expanding it to 15 stores. In 2019, he joined forces with Alcanna Inc., helping it become one of Canada's largest liquor retailers. Zachary George, CEO of SNDL, thanked Vander for his contributions. "We want to thank Tank for his exceptional leadership and wish him continued success in his future endeavors."
Navroop Sandhawalia, VP of finance for Liquor Retail at SNDL, <a href="https://www.prnewswire.com/news-releases/sndl-announces-departure-of-liquor-segment-president-302244048.html#:~:text=CALGARY%2C%20AB%2C%20Sept.%2010,SNDL%20to%20pursue%20new%20opportunities">will take over</a> as interim president of the liquor division while the company searches for a permanent replacement.
Get Benzinga&#8217;s exclusive analysis and top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">SNDL Stock Performance Compared To Other Canadian Cannabis Companies</h3>
After the market closed on Tuesday, September 10, 2024, SNDL experienced a slight dip in its stock price, closing at $2.10, down 0.47%. Trading volume for SNDL reached 1,697,281 shares, reflecting continued investor activity as the company transitions leadership in its Liquor Division.
In comparison, other notable <a href="https://www.benzinga.com/topic/canada-cannabis">Canadian cannabis stocks</a> also saw mixed results:
<ul>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) closed at $5.55, down 1.56%, with 568,615 shares traded. Despite a lower percentage drop than SNDL, Aurora's stock showed greater volatility with a day high of $5.90 and a low of $5.55.</li>
<li>OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) fared slightly better, closing at $1.83, up 1.1%. The stock saw a trading volume of 297,194 shares, indicating moderate investor interest.</li>
<li>Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) closed at $1.69, down 0.59%, with a significant trading volume of 18,592,650 shares, reflecting heightened activity compared to other stocks.</li>
<li>High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) showed positive momentum, increasing by 3.3% to close at $2.13, with 447,671 shares traded, positioning it among the stronger performers in the sector today.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) closed at $4.84, down 1.03%, with a volume of 2,777,417 shares. Despite the decline, Canopy saw considerable trading activity, suggesting continued investor engagement.</li>
</ul>
Overall, <a href="https://www.benzinga.com/markets/cannabis/24/08/40631613/sndl-wins-bid-for-indiva-secures-major-deal-to-boost-cannabis-edibles-market-share-in-canada">SNDL's performance </a>was relatively stable compared to its peers, with many Canadian cannabis stocks experiencing minor fluctuations throughout the trading day. The trading volumes across the sector reflected ongoing interest but no significant market shifts following the day&#8217;s developments.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40783919/cannabis-flower-no-thanks-canadians-shift-to-pre-rolls-vapes-as-market-eyes-c-5-47b">Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls &amp; Vapes As Market Eyes C$5.47B</a>

Retail Sales

Management

 CGC

HITI

SNDL

TLRY

Last Call For SNDL's Liquor President: Stock On The Rocks Amid Leadership Changes

The Company intends to use the net proceeds of the Offering to repay all of its outstanding borrowings under its term loan A facility, to pay fees and expenses in connection with the Offering, and for general corporate purposes.

Offerings

PHIN

PHINIA Reports Pricing Of Upsized Private Offering of $450M Of Senior Notes Due 2032

Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) has outperformed the market over the past 15 years by 10.88% on an annualized basis producing an average annual return of 22.37%. Currently, Copart has a market capitalization of $47.64 billion. 
Buying $1000 In CPRT: If an investor had bought $1000 of CPRT stock 15 years ago, it would be worth $21,197.75 today based on a price of $49.51 for CPRT at the time of writing.
<h3>Copart's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726003821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CPRT

$1000 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today

Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) has outperformed the market over the past 5 years by 10.72% on an annualized basis producing an average annual return of 23.55%. Currently, Brown &amp; Brown has a market capitalization of $29.42 billion. 
Buying $1000 In BRO: If an investor had bought $1000 of BRO stock 5 years ago, it would be worth $2,866.31 today based on a price of $103.13 for BRO at the time of writing.
<h3>Brown &amp; Brown's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726003816_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Brown & Brown 5 Years Ago Would Be Worth This Much Today

This represents a&nbsp;$200 million&nbsp;increase from the previously announced size of the offering. The Notes will have a maturity date of January 15, 2030. The closing of the offering of the Notes is expected to occur on September 13, 2024, subject to customary closing conditions. The Notes will be issued at par and guaranteed on a senior unsecured basis by the Company and certain of its U.S. subsidiaries.

Avis Budget Subsidiaries Prices Private Offering Of $700M Of 8.250% Senior Notes Due 2030

Barnes &amp; Noble Education, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) reported its first-quarter financial results after Tuesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/09/g40804179/barnes-noble-education-reports-first-quarter-fiscal-year-2025-financial-results">details from the report.&nbsp;</a>
The Details: Barnes &amp; Noble Education reported quarterly sales of $263.4 million, which missed the analyst consensus estimate of $268.321 million by 1.83% and is a 0.29% from the same period last year. The company said it is a highly seasonal business, and the first quarter is historically a period of low sales activity for the company.
The decrease in quarterly revenue was primarily driven by a net decrease in physical locations, many of which were closures of underperforming stores, the company said. Revenues from BNC First Day programs increased approximately $19.6 million, or 32%, helping to offset much of the decline.
Read Next: <a href="https://www.benzinga.com/news/24/09/40799508/whats-going-on-with-apple-stock-following-iphone-16-release">What&#8217;s Going On With Apple Stock Following iPhone 16 Release?</a>
&#8220;It was a very busy quarter as we completed our milestone equity and refinancing transactions and worked hard to prepare for the upcoming Fall Rush with our store teams, vendors and other business partners. We are excited by the momentum and fresh energy as we enter the new academic year,&#8221; said Jonathan Shar, CEO of Barnes &amp; Noble Education. 
Outlook: The company anticipates spending approximately $20 million on capital expenditures in fiscal year 2025, with the bulk of those investments focused on store improvements and technology. Barnes &amp; Noble Education did not provide formal guidance, but said &#8220;management&#8217;s budget goals target a material improvement in fiscal year 2025 GAAP operating results and Adjusted EBITDA versus last year.&#8221; 
BNED Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Barnes &amp; Noble Education shares are down 5.13% after-hours at $10.27 after dropping 5% in regular trading Tuesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40799524/lucid-showcases-new-gravity-suv-teases-affordable-crossover-ev">Lucid Showcases New Gravity SUV, Teases Affordable Crossover EV</a></li>
</ul>
Photo: Mediamodifier from Pixabay

Earnings

Entertainment

Education

Movers

BNED

Barnes & Noble Education Stock Slips Following Q1 Results

The study, which included 40 patients, showed that prophylaxis with 8-mg dexamethasone taken for two days prior to the first infusion met the primary endpoint of incidence of IRRs at Cycle 1 Day 1 (C1D1), with an all-grades IRR rate for IV RYBREVANT&reg;&nbsp;of&nbsp;22.5 percent.
This represents a three-fold reduction in the incidence of IRRs compared to standard management of IRRs with IV RYBREVANT&reg;, where historic data has observed an all-grades incidence rate of&nbsp;67.4 percent.

Johnson & Johnson Says Dexamethasone Reduces Infusion-Related Reactions In Patients With EGFR-Mutated Non-Small Cell Lung Cancer Treated With Intravenous RYBREVANT

The cash dividend is payable on September 27, 2024 to shareholders of record as of September 20, 2024.

Dividends

First American Financial Boosts Quarterly Cash Dividend By 2% From $0.53 To $0.54 Per Share

Vice President Kamala Harris has gained endorsements from many politicians, business leaders and members of Hollywood, with singers including Beyonce throwing support her way with the <a href="https://www.benzinga.com/general/entertainment/24/08/40168992/beyonc-to-donate-4m-to-harris-in-bid-against-trump-she-feels-the-stakes-are-too-high">use of her songs.</a>
Global superstar Taylor Swift is believed to be a supporter of the Democratic Party and previously backed the Biden/Harris campaign, but has yet to show public support for Harris. Could that change in the final two months?
What Happened: There were reports that Beyonce or Swift <a href="https://www.benzinga.com/general/politics/24/08/40429245/2024-dnc-preview-democrats-to-rally-around-harris-walz-with-biden-obamas-clintons-and-more-will-">would be a surprise guest</a> at the 2024 Democratic National Convention, but the claims proved to be false.
Swift, who has been backing Democratic Party candidates in recent years, has yet to make an endorsement for the 2024 presidential election.
The musician previously backed a Democratic candidate for Senate in Tennessee in the 2018 election, as reported by <a href="https://variety.com/2024/music/opinion/taylor-swift-kamala-harris-1236138123/">Variety</a>. The endorsement was Swift&#8217;s first time speaking out on political matters.
Swift backed Joe Biden and running mate Harris in the 2020 election.
A potential endorsement of Harris could be a major turning point in the 2024 election, with Swift's celebrity status among the biggest figures globally and a huge reach among females and young voters.
Swift's political endorsements were previously covered in the 2020 Netflix documentary "Miss Americana" where the singer told her father that she needed "to be on the right side of history" by speaking out politically despite him opposing this. Swift also mentioned that she wishes she would have spoken up in the 2016 election previously.
The singer's quietness about the 2024 election also comes with Republican candidate Donald Trump using fake AI-generated images alleging Swift and her fans had endorsed him. Swift did not make a statement on the images.
Some Swift fans that support Harris and the Democratic Party are also critical of her friendship with Brittany Mahomes, wife of Kansas City Chiefs star Patrick Mahomes. Brittany Mahomes has been a vocal supporter of Trump and even drew a thank you from the former president for her support. Swift and boyfriend Travis Kelce, also of the Chiefs, have often been seen with the Mahomes duo.
Another reason Swift may not be speaking out on her political leanings could be fear of repercussions. A terrorist attack plan on Swift's concert in Vienna was stopped before the show, which was ultimately cancelled. Swift made a brief statement on the event.
"Let me be very clear: I am not going to speak about something publicly if I think doing so might provoke those who would want to harm the fans who come to my shows," Swift said.
The Variety article suggests that Swift may have more at stake now, given her global superstardom is far greater than it was when she previously endorsed political candidates.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent091024">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: An endorsement from Swift is still a possibility, as she backed Biden in October 2020, a month before the election.
On prediction market Polymarket, over $409,000 has been bet on the market of whether Swift will endorse Harris before the 2024 election. The market leans to yes for an official endorsement coming before Nov. 4 at 76% as of<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40791846/taylor-swift-to-endorse-kamala-harris-77-chance-is-free-money-from-delusional-republicans-"> the time of writing.</a>
While the majority still believe she will endorse Harris, this figure has dropped from 88% in mid-August and 92% at the beginning of the month.
While Swift may not be publicly endorsing a candidate, that hasn't stopped her fans who are commonly known as Swifties from speaking out and<a href="https://www.benzinga.com/general/entertainment/24/08/40603751/taylor-swift-fans-raise-100k-for-kamala-harris-original-cat-lady-carole-king-elizabeth-warr"> raising money for the vice president.</a>
A "Swifties for Kamala Rally" took place recently and featured guest appearances from legendary songwriter and singer Carole King and Senator Elizabeth Warren (D-Mass.). The group raised over $100,000 in donations for Harris' 2024 election campaign.
In September, on National Voter Registration Day, Swift posted to her Instagram stories encouraging her fans to register to vote.
"I've been so lucky to see so many of you guys at my U.S. shows recently. I've heard you raise your voices, and I know how powerful they are. Make sure you're ready to use them in our elections this year!" Swift said, as shared by&nbsp;<a href="https://www.npr.org/2023/09/22/1201183160/taylor-swift-instagram-voter-registration" target="_blank" rel="noreferrer noopener">NPR</a>.
Swift's post was non-partisan and included a link to the voter registration at Vote.org.
A total of 35,252 people registered to vote during the 2023 National Voter Registration Day, marking the highest turnout since 2020. This figure represents a 23% increase from the previous year. Additionally, the number of 18-year-old voters doubled compared to 2022 during the 2023 campaign.
It&#8217;s unknown how many of the registrations Swift was directly responsible for. But the Vote.org website saw a 1,226% jump in site visits in the hour after Swift's Instagram story.
A potential Swift endorsement could be a key event in the 2024 election.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/06/39346067/donald-trump-shakes-off-potential-taylor-swift-endorsement-for-joe-biden-why-would-she-endo">Donald Trump Shakes Off Potential Taylor Swift Endorsement For Joe Biden: &#8216;Why Would She Endorse This Dope&#8217;</a></li>
</ul>
Photo: Shutterstock

Taylor Swift Endorsed Biden And Harris In 2020 — Will She Back Vice President Again In Final Stretch Of 2024 Election?

The British Cannabis Industry Council (CIC) issued a new report reminding housing providers in the UK of their obligations under the Equality Act 2010, which prohibits discrimination based on various disabilities.
The report, <a href="https://www.cicouncil.org.uk/app/uploads/2024/09/FINAL_CIC24_08-The-Use-of-Prescription-Cannabis-in-Buildings-1.pdf" target="_blank" rel="noreferrer noopener">The Use of Prescription Cannabis in Buildings</a> insists that landlords, property managers and housing associations must allow the use of prescribed medical marijuana within the confines of a tenant's private space and ensure privacy and confidentiality.
Any restrictions on the possession and consumption of prescribed medical cannabis is considered a discrimination and violates the Equality Act. Breaching the Act this way could lead to housing providers being taken to court or added to a &#8216;rogue&#8217; landlord database.
"Housing providers must treat prescription cannabis patients like any other medical patients, and indeed should take steps to ensure patients can consume their medication at home," stated the report author Mohammad Wasway of PatientsCann. "We urge landlords and housing associations to proactively engage with tenants and leaseholders, to ensure that do not discriminate against patients with disabilities."
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
The paper, reviewed by lawyer Robert Jappie, also provides guidance for patients regarding their legal rights.
"The Cannabis Industry Council will be engaging with housing providers to help them understand their legal obligations and support their tenants and leaseholders," said CIC Standards Working Group chair Elisabetta Faenza in a statement. "We believe it would be proportionate for landlords who continue to deny patients their basic rights to be added to ‘rogue' landlord databases or indeed be taken to court."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39651496/will-uk-cannabis-laws-change-under-new-labour-government-doesnt-look-that-way-just-yet">Will UK Cannabis Laws Change Under New Labour Government? Doesn&#8217;t Look That Way Just Yet</a>
<h2 class="wp-block-heading">Medical Marijuana In The UK</h2>
The need for cannabis as medicine was highlighted by two cases involving children with severe epilepsy. One is&nbsp;Billy Caldwell&nbsp;and the other is&nbsp;Alfie Dingley.&nbsp;They were both&nbsp;using cannabis low-dose THC&nbsp;oil&nbsp;to treat their seizures. Thanks to them and their families the need for cannabis as medicine was brought to the public, and the UK decided to embrace it in 2018.
Since then, the number of medical marijuana patients grew significantly. : &#8220;In July, Mamedica, a medical marijuana clinic in Westminster, <a href="https://www.bbc.com/news/articles/crgkxv6ljp4o" target="_blank" rel="noreferrer noopener">told </a>the BBC that patient numbers grew more than tenfold in 2023, from 250 to 2,750.
CEO Jon Robson said this was down to a &#8220;large number of patients who are transitioning to us not just from the illicit market, but because they haven&#8217;t found the treatments that the NHS can provide to be sufficient for their conditions&#8221;.
While it is possible to access medical marijuana through the National Health Service (NHS), this rarely occurs and only in severe cases of epilepsy, chemotherapy-induced nausea or certain cases of muscle stiffness associated with multiple sclerosis (MS). Since medical marijuana is not widely available via&nbsp;the NHS, many families struggle to&nbsp;<a href="https://www.benzinga.com/markets/cannabis/23/10/35388605/europes-high-uk-parents-need-nhs-help-for-daughters-seizures-thc-mmj-flowers-in-switzerland-more" target="_blank" rel="noreferrer noopener">afford life-saving medicine for</a> their children.
Read Next :
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/06/32693057/uk-moms-concern-as-no-doctor-will-prescribe-cannabis-for-her-daughters-300-daily-seizures">UK Mom&#8217;s Concern As No Doctor Will Prescribe Cannabis For Her Daughter&#8217;s 300 Daily Seizures</a></li>
</ul>
Photo generated with AI

Eurozone

British Landlords Must Allow Medical Marijuana Consumption And Ensure Privacy, Per New Report

Mark Sutton, who has continued to serve in the role of Chairman of the Board since retiring as CEO in May, will retire from the Board on&nbsp;September 30, 2024.

International Paper Names Andy Silvernail As Chairman In Addition To His Role As CEO, Effective October 1, 2024; Mark Sutton To Retire From Board

Leonardo DRS Delivers, Ahead Of Schedule, Critical C5I Capabilities For The Australian Army's Heavy Armoured Capability Systems

Kosmos Energy Reports Pricing Of $500M Of Its 8.750% Senior Notes Due 2031

Advanced Environmental Recycling Technologies

AERT

Aeries Technology Receives Deficiency Notification Letter From Listing Qualifications Staff Of Nasdaq

During the last three months, 6 analysts shared their evaluations of AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $94.33, with a high estimate of $108.00 and a low estimate of $66.00. This current average reflects an increase of 3.47% from the previous average price target of $91.17. 
<img src="https://www.benzinga.com/files/images/story/2024/1726002021_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of AppLovin by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Heaney</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$108.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Mark Zgutowicz</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Sell</td>
<td>$66.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Nick McKay</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Nick McKay</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$97.00</td>
<td>$97.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to AppLovin. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AppLovin compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of AppLovin's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into AppLovin's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/APP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on AppLovin analyst ratings.</a>
<h2>All You Need to Know About AppLovin</h2>
AppLovin Corp is a mobile app technology company. It focuses on growing the mobile app ecosystem by enabling the success of mobile app developers. The company's software solutions provide tools for mobile app developers to grow their businesses by automating and optimizing the marketing and monetization of their applications.
<h3>Financial Insights: AppLovin</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: AppLovin's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 43.98%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: AppLovin's net margin excels beyond industry benchmarks, reaching 28.69%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): AppLovin's ROE stands out, surpassing industry averages. With an impressive ROE of 39.35%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): AppLovin's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.88% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: AppLovin's debt-to-equity ratio is notably higher than the industry average. With a ratio of 4.32, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Peeling Back The Layers: Exploring AppLovin Through Analyst Insights

Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) has outperformed the market over the past 5 years by 22.08% on an annualized basis producing an average annual return of 34.9%. Currently, Howmet Aerospace has a market capitalization of $38.02 billion. 
Buying $1000 In HWM: If an investor had bought $1000 of HWM stock 5 years ago, it would be worth $4,486.02 today based on a price of $93.15 for HWM at the time of writing.
<h3>Howmet Aerospace's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726002014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $4,500 Today

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 5 years by 13.7% on an annualized basis producing an average annual return of 26.53%. Currently, Parker Hannifin has a market capitalization of $74.73 billion. 
Buying $100 In PH: If an investor had bought $100 of PH stock 5 years ago, it would be worth $318.88 today based on a price of $581.10 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726002009_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

Vangst, cannabis industry&#8217;s leading hiring platform, announced Tuesday its acquisition of GreenForce, a temporary staffing agency operating in <a href="http://benzinga.com/topic/oregon-cannabis">Oregon</a> and <a href="http://benzinga.com/topic/arizona-cannabis">Arizona</a>. This move, effective immediately, positions Vangst for further expansion both regionally and nationally, <a href="https://www.benzinga.com/markets/cannabis/24/04/38224658/cannabis-platform-vangst-acquires-cannabizteams-temp-staffing-division-amid-hiring-surge">marking its second major buyout in 2024</a>.
<h3 class="wp-block-heading">GreenForce: Pioneers In Cannabis Labor Services</h3>
Founded in 2016, GreenForce has carved a niche in providing specialized labor services such as harvesting, cultivation and trimming, primarily catering to licensed <a href="http://benzinga.com/cannabis">cannabis</a> operators. With over 100 active clients across Oregon and Arizona, GreenForce&#8217;s integration into Vangst is anticipated to leverage its existing footprint to fuel growth plans.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">CEO's Perspective</h3>
Ryan Rosenfeld, the founder and CEO of GreenForce, expressed enthusiasm about the new chapter under Vangst. &#8220;This transaction will give us the opportunity to expand more aggressively than ever before, provide an even more superior experience to our customers and workforce and most importantly, continue to uplift the cannabis industry,&#8221; Rosenfeld <a href="https://www.prnewswire.com/news-releases/vangst-acquires-greenforce---cannabis-hiring-is-back-302243265.html">said</a> in a press release. He will join Vangst as the chief business officer, bringing his extensive industry experience to the fore.
Similarly, Karson Humiston, founder and CEO of Vangst, praised Rosenfeld as a &#8220;phenomenal entrepreneur&#8221; and emphasized the shared goal of automating cannabis hiring. &#8220;We are honored to welcome GreenForce customers and Ryan to the Vangst family,&#8221; said Humiston.
<h3 class="wp-block-heading">Vangst&#8217;s Vision For 1 Million Cannabis Jobs</h3>
This acquisition strengthens Vangst&#8217;s foothold as an industry leader in cannabis hiring and increases its client base to over 1,800, encompassing 90% of the top U.S. cannabis operators. Vangst boasts a network of 150,000 workers and is heavily investing in technology to streamline the hiring process for businesses and employees alike.
According to its 2024 jobs report, the company plays a crucial role in a rapidly expanding market that expects to see employment figures surge to 1,000,000 full-time cannabis positions within the next five years. By acquiring GreenForce, Vangst reinforces its mission to fill every job—temporary and full-time—in the <a href="https://www.benzinga.com/markets/cannabis/24/03/37521749/unpacking-the-58b-cannabis-market-boom-bdsa-forecasts-for-2028">cannabis industry</a>.
Related News
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40782361/cannabis-stocks-react-to-trumps-marijuana-comments-see-which-ones-posted-solid-gains">Cannabis Stocks React To Trump&#8217;s Marijuana Comments: See Which Ones Posted Solid Gains</a></li>
</ul>

Cannabis Hiring Platform Vangst Predicts 1M Full-Time Marijuana Jobs By 2029, Announces Acquisition Of GreenForce Staffing Agency

Universal Technical Institute CFO Troy Anderson Resigns, Effective October 11, 2024, To Accept Position At Another Public Company; Christine Kline Named As Interim CFO

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

OVH

OVH (OVHGY) Forecast

OVH (OTC:OVHGY) Stock, Quote.Headers.trade-ideas